N/A N=20 Chlorhexidine Drying Time
Drying Time
Primary: Length of Drying Time — 123 seconds
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=1,452 Study of Azithromycin to Prevent Recurrent Trichiasis Following Surgery in Ethiopia
Trichiasis
Primary: Recurrent Trichiasis in Tetracycline and Azithromycin Groups — 45; 62 Participants — p=.047
N/A N=15 Intravenous Interferon During Liver Transplant
Hepatitis C · Cirrhosis
Primary: HCV RNA Result — 924,082; 3,731,749 IU/ml
Phase 2 N=124 A Study of Bevacizumab (Avastin) in Combination With Temozolomide (TMZ) and Radiotherapy in Paediatric and Adolescent Participants With High-Grade Glioma
High Grade Glioma
Primary: Event-Free Survival (EFS) as Assessed by the Central Radiology Review Committee (CRRC) — 11.79; 8.21 months — p=0.1292
Phase 2 N=240 A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX)
Psoriatic Arthritis
Primary: American College of Rheumatology (ACR) 20 Response Rate at Week 12: ABT-122 Versus Placebo — 25.0; 64.8; 75.3 percentage of participants — p=<0.001
Phase 2 N=15 ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment
Male Breast Cancer · Recurrent Breast Cancer · Stage IIIA Breast Cancer
Primary: Safety Evaluated by Collecting Study Related Toxicity as Assessed by CTCAE v3.0 — 15 Participants
Phase 2 N=209 Safety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years Old
Influenza
Primary: Number of Seroconverted Subjects for Haemagglutination Inhibition (HI) Antibodies Against Flu A/CAL/7/09 H1N1 Strain — 75; 74; 57 Participants
Phase 3 N=158 Efficacy and Safety of a New Formulation of Chondroitin Sulfate and Glucosamine Sulfate to Treat Knee Osteoarthritis
Knee Osteoarthritis
Primary: Change in Pain According to VAS (0-100 mm) — -11.86; -20.57 units on a scale — p=<0.0307
N/A N=10 Study of the Feasibility of Magnetic Navigated Capsule Endoscope in the Upper Gastrointestinal Tract Examination
Healthy Patient on Good Condition
Primary: Assess the Completeness of Capsule Endoscopy — 100; 85.2; 86.1 percentage of mucosa visibility
N/A N=15 Clinical Evaluation of Propel Nova Sinus Implant in Peripheral Sinus Ostia
Chronic Sinusitis
Primary: Device Placement Success Rate — 100; 95.2 Percentage of attempted sinuses
Phase 2 N=34 A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy
Hepatic Cancer
Primary: Treatment Response — 16; 14; 4 Participants
Phase 4 N=106 Comparing Acute Pain Management Protocols for Patients With Sickle Cell Disease
Sickle Cell Disease
Primary: Difference in Pain Score as Measured by a Visual Analogue Scale (VAS) — 26.4; 43.0 Units on a 100 mm VAS — p=0.0311
Phase 3 N=1,147 Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
PONV
Primary: Number of Participants With Complete Response — 330; 268 Participants — p=<0.001
N/A N=177 Ease of Use of New Blood Glucose Meter With In-built Insulin Calculator at Home Study
Diabetes Mellitus
Primary: Overall User Preference for the FreeStyle InsuLinx System Compared to Current Method. — 125 participants — p=<0.0001
Phase 3 N=148 Efficacy of Ropivacaine (With Epinephrine) in BABA Endoscopic and Robotic Thyroidectomy
Thyroid Neoplasm · Goiter
Primary: NRS Pain Scores for the First 12 Hours — 4.93; 4.12; 4.50; 3.69 points — p=0.008